• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV-1/2 AG/AB COMBO; IVD FOR HIV 1/2 AG/AB Back to Search Results
Catalog Number 7D2648
Device Problem False Positive Result (1227)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 11/22/2018
Event Type  malfunction  
Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lots: 106477, 107755, 108399, 109469, 110100, 109895, 108250, and 108941 with the following internal whole blood and serum/plasma: (b)(6).All test results were valid and performed as expected.Additionally, the manufacturing batch records for lots 106477, 107755, 108399, 109469, 110100, 109895, 108250, and 108941 were reviewed.These lots met the required release specifications.A review of the complaints reported as false positive related to the below lot numbers showed that the complaint rate is: (b)(4).The evidence available does not indicate that the product is performing outside label claims.Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that this device lot is performing within labeled claims.
 
Event Description
A customer reported nine (9) (b)(6) results with the alere determine hiv-1/2 ag/ab combo test.This report represents six (6) of the nine (9) (b)(6) (ag/ab not specified) alere determine hiv 1/2 ag/ab combo patient results reported from a customer.Confirmation testing (methodology not otherwise specified) was negative/nonreactive.The patient gender, pregnancy status, treatment and outcome were unknown.There is insufficient information to determine if a malfunction occurred.Attempts to gain additional information were not successful.
 
Event Description
A customer reported nine (9) false positive results with the alere determine hiv-1/2 ag/ab combo test.No patient information was provided until 26 december 2019.This supplemental report represents six (6) of nine (9).A customer reported a false positive antibody (ab) result (sample type not otherwise specified) with the alere determine hiv 1/2 ag/ab combo.Confirmation testing with the abbott architect was negative/nonreactive.The patient was reported as male.Patient treatment and outcome are unknown.Attempts to gain additional information were not successful.Per the alere determine hiv-1/2 ag/ab combo product insert: a reactive result using alere determine hiv-1/2 ag/ab combo suggests the presence of hiv-1 p24 antigen and/or antibodies to hiv-1 and/or hiv-2 in the sample.The reactive result is interpreted as preliminary positive for hiv-1 p24 antigen and/or antibodies to hiv-1 and/orhiv-2.Alere determine hiv-1/2 ag/ab combo is intended as aid in the diagnosis of infection with hiv-1/2.Reactive test results should be confirmed by additional testing using other tests.The risk will not cause or contribute to a death or serious injury.
 
Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 101439 with the following internal s/p control samples: hiv-1 positive, hiv-2 positive, p24 positive, and hiv negative.All test results were valid and performed as expected.Additionally, the manufacturing batch records for lot 101439 were reviewed.This lot met the required release specifications.(b)(4).The evidence available does not indicate that the product is performing outside label claims.Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that this device lot is performing within labeled claims.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV-1/2 AG/AB COMBO
Type of Device
IVD FOR HIV 1/2 AG/AB
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
MDR Report Key9403252
MDR Text Key220021988
Report Number1221359-2019-00081
Device Sequence Number1
Product Code MZF
UDI-Device Identifier10811877010293
UDI-Public011081187701029310106477
Combination Product (y/n)N
PMA/PMN Number
BP120037-0
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 01/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/23/2020
Device Catalogue Number7D2648
Device Lot Number101439
Was Device Available for Evaluation? No
Date Manufacturer Received12/27/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age25 YR
-
-